MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 08-19-2024
Talis Biomedical Corporation Retained Earnings 2011-2026 | TLIS
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Talis Biomedical Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -540 M | -478 M | -365 M | - | -81.8 M | -54.3 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -54.3 M | -540 M | -304 M |
Quarterly Retained Earnings Talis Biomedical Corporation
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -562 M | -553 M | -540 M | -527 M | -511 M | -496 M | -478 M | -451 M | - | -398 M | -365 M | -336 M | -298 M | -233 M | -173 M | -173 M | -173 M | -173 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -173 M | -562 M | -379 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abbott Laboratories
ABT
|
49.8 B | $ 102.87 | 0.48 % | $ 179 B |  USA |
 |
Align Technology
ALGN
|
2.48 B | $ 170.6 | -1.23 % | $ 12.8 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 10.83 | -3.82 % | $ 1.63 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
-307 M | $ 34.44 | 2.56 % | $ 1.59 B | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 9.37 | 2.52 % | $ 265 M | USA |
 |
Accuray Incorporated
ARAY
|
-519 M | $ 0.42 | 6.82 % | $ 43.2 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.58 | 6.52 % | $ 36.1 M | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 9.63 | 0.94 % | $ 345 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 23.29 | -1.52 % | $ 197 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 36.76 | 1.88 % | $ 5.48 K | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 62.82 | 1.32 % | $ 93 B | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 81.05 | -0.26 % | $ 47.4 B | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 34.79 | -2.08 % | $ 1.08 B | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Aethlon Medical
AEMD
|
-168 M | $ 2.12 | -1.4 % | $ 3.31 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 12.03 | 1.43 % | $ 1.63 B | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 1.86 | 9.41 % | $ 1.13 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 9.53 | -0.42 % | $ 734 M | USA |
 |
Inogen
INGN
|
-176 M | $ 6.21 | -0.96 % | $ 165 M | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 54.99 | 2.52 % | $ 1.61 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 16.06 | -1.41 % | $ 377 M | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 0.98 | 3.17 % | $ 16.6 M | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 86.85 | 0.47 % | $ 3.02 B | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 63.79 | -1.3 % | $ 3.48 B |  Britain |
 |
LENSAR
LNSR
|
-178 M | $ 6.06 | 1.51 % | $ 72.5 M | USA |